Skip to main content
. 2017 Oct 12;8(58):98405–98416. doi: 10.18632/oncotarget.21846

Figure 4. Western blot analysis of stemness marker expression in miPS-LLCcm cells.

Figure 4

(A) Cultured miPS-LLCcm cells were treated with different concentrations of deferasirox and DFO for 48 hours. Cells were then harvested and total protein was analyzed for the expression of indicated proteins. Deferasirox and DFO decreased the expression of stemness markers. (B) Densitometry analysis of the western blots also showed deferasirox and DFO significantly decreased the expression of the stemness markers, Nanog and Oct3/4. Data are represented as average ± S.E.M. (n = 3) *p < 0.05, **p < 0.01, ***p < 0.001.